Mesuximide

Mesuximide
	File:Mesuximide.svg
Clinical data
Pregnancy; category	US: C (Risk not ruled out) ; ;
Routes of; administration	Oral
ATC code	N03AD03 (WHO) ;
Legal status
Legal status	US: ℞-only ;
Pharmacokinetic data
Metabolism	Hepatic (demethylation and glucuronidation)
Elimination half-life	1.4–2.6 hours (mesuximide); 28–38 hours (active metabolite)
Excretion	Renal
Identifiers
	IUPAC name 1,3-dimethyl-3-phenyl-pyrrolidine-2,5-dione;
CAS Number	77-41-8;
PubChem CID	6476;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C12H13NO2
Molar mass	203.237 g/mol

Mesuximide (or methsuximide) is an anticonvulsant medication. It is sold by Pfizer under the name Petinutin®.^[1]

References

↑ Pfizer AG (2005). "Petinutin® (Mésuximide)". Official Pfizer AG Website (in French). Unknown parameter |accessyear= ignored (|access-date= suggested) (help); Unknown parameter |accessmonthday= ignored (help)

This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it.

Clinical data
File:Mesuximide.svg
Pregnancy category	US: C (Risk not ruled out)
Routes of administration	Oral
ATC code	N03AD03 (WHO)
Legal status
Legal status	US: ℞-only
Pharmacokinetic data
Metabolism	Hepatic (demethylation and glucuronidation)
Elimination half-life	1.4–2.6 hours (mesuximide) 28–38 hours (active metabolite)
Excretion	Renal
Identifiers
IUPAC name 1,3-dimethyl-3-phenyl-pyrrolidine-2,5-dione
CAS Number	77-41-8
PubChem CID	6476
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₂H₁₃NO₂
Molar mass	203.237 g/mol